Member Info for chrishutch

Fully funded till the end of the year (2022) according to latest broker notes.

Lol, I was like the kiss of death on the price here today! Someone not got a West Ham sense of humour.

I am ok watching this bob about between here and the 1p area for the time being. We just need that little flashing dot and we should start to rerate.

Another mid afternoon opp, almost tradable between here and 1p range

Come on Cizzle we have loaded up down here and now it’s time to start giving the market some of that sizzling promotion and news we want

:-)

Has to move up a league!

This will be in the 1s this week

I was away on Friday and missed this dip in price.

We have movement!

haha i will be happy when this is in the 1s

For exactly the same amount as the earlier sell. Potentially, a fat finger trade.

Zak has this penciled in for a first target, I was hopeful for a bit more.

https://www.**********.co.uk/articles/traders-cafe-with-zak-mir-the-top-20-stocks-for-2022-countdown-14-to-10-5cdc986/

Could pay off handsomely.

It seems to be trading in a range while we wait and we are around the bottom of that range.Hopefully, a lift from these levels without news and a nice leap forward on news.

I think it goes up, let’s see.

Any thoughts?

I think there is potentially a decent trade here from this level.

Be nice if it went red to blue!

I took a few more

Fair play, made me smile.

;-)

Just reiterating that it is undervalued in my view, it has dropped a long way from 10p IPO and 5p Seed money on low volume caused by a lack of promotion but a causal read of the last 6 months RNS will show that the company are achieving and are moving solidly in the right direction.

Market cap £7 million is too low

*Cash last call £1.43m. (I estimate around 900k left and given very low burn rate this should take us to end of 2022)
*SGSC : UK commercial deal (amount incoming unknown) and royalty deal (up to £5m.)
*CHINA: (MoU) with 2 partners for the development, supply and commercialisation ( supply and royalties being negotiated)
* FairJourney: collaboration deal with FairJourney Biologics (FJB) for the development and supply (being negotiated)
* Grants, rebates, credits, etc to come
* more deals, partnerships and collaborations to come all adding value.
* IR has said that all deals with SGS remain in place and they hope to have something positive to share re agreements in due course.

When we consider the one off costs now done, the low burn rate, the news flow, the deals, existing partnerships and new ones, China and huge potential the products have then then current cap is very cheap. I will stick my neck out and say this will have a great 2022.